These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 39374452
1. Intended And Unintended Outcomes After FDA Pediatric Antidepressant Warnings: A Systematic Review. Soumerai SB, Koppel R, Naci H, Madden JM, Fry A, Halbisen A, Angeles J, Koppel J, Rubin R, Lu CY. Health Aff (Millwood); 2024 Oct; 43(10):1360-1369. PubMed ID: 39374452 [Abstract] [Full Text] [Related]
2. Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study. Lu CY, Zhang F, Lakoma MD, Madden JM, Rusinak D, Penfold RB, Simon G, Ahmedani BK, Clarke G, Hunkeler EM, Waitzfelder B, Owen-Smith A, Raebel MA, Rossom R, Coleman KJ, Copeland LA, Soumerai SB. BMJ; 2014 Jun 18; 348():g3596. PubMed ID: 24942789 [Abstract] [Full Text] [Related]
4. Effect of the FDA Black Box Suicidality Warnings for Antidepressants on Suicide Rates in the USA. Plöderl M, Hengartner MP. Crisis; 2023 Mar 18; 44(2):128-134. PubMed ID: 34915730 [Abstract] [Full Text] [Related]
6. News coverage of FDA warnings on pediatric antidepressant use and suicidality. Barry CL, Busch SH. Pediatrics; 2010 Jan 18; 125(1):88-95. PubMed ID: 19969614 [Abstract] [Full Text] [Related]
8. Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study. Olfson M, Marcus SC, Shaffer D. Arch Gen Psychiatry; 2006 Aug 18; 63(8):865-72. PubMed ID: 16894062 [Abstract] [Full Text] [Related]
9. Caution over antidepressants may have backfired. Wallis L. Am J Nurs; 2014 Sep 18; 114(9):16. PubMed ID: 25166232 [Abstract] [Full Text] [Related]
11. Antidepressants use in pediatric populations. Gören JL. Expert Opin Drug Saf; 2008 May 18; 7(3):223-5. PubMed ID: 18462180 [Abstract] [Full Text] [Related]
12. Pediatric antidepressant use after the black-box warning. Busch SH, Barry CL. Health Aff (Millwood); 2009 May 18; 28(3):724-33. PubMed ID: 19414881 [Abstract] [Full Text] [Related]
13. Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults. Katz LY, Kozyrskyj AL, Prior HJ, Enns MW, Cox BJ, Sareen J. CMAJ; 2008 Apr 08; 178(8):1005-11. PubMed ID: 18390943 [Abstract] [Full Text] [Related]
14. National antidepressant prescribing in children and adolescents with mental health disorders after an FDA boxed warning. Mittal M, Harrison DL, Miller MJ, Brahm NC. Res Social Adm Pharm; 2014 Apr 08; 10(5):781-90. PubMed ID: 24355381 [Abstract] [Full Text] [Related]
15. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Posner K, Oquendo MA, Gould M, Stanley B, Davies M. Am J Psychiatry; 2007 Jul 08; 164(7):1035-43. PubMed ID: 17606655 [Abstract] [Full Text] [Related]
17. Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population? Akiskal HS, Benazzi F. J Affect Disord; 2006 Aug 08; 94(1-3):105-10. PubMed ID: 16766043 [Abstract] [Full Text] [Related]
18. Pediatric prescribing practices and the FDA Black-box warning on antidepressants. Cheung A, Sacks D, Dewa CS, Pong J, Levitt A. J Dev Behav Pediatr; 2008 Jun 08; 29(3):213-5. PubMed ID: 18550990 [Abstract] [Full Text] [Related]